First Command Financial Services, Inc. Gilead Sciences, Inc. Transaction History

First Command Financial Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $5,665 - $6,455	-100 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $431 - $474	-7 Reduced 6.54%	100 $6,000
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $4,640 - $5,203	-75 Reduced 41.21%	107 $7,000
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $11,018 - $14,378	182 New	182 $11,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $6,477 - $8,453	-107 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$64.88 - $75.68 $6,942 - $8,097	107 New	107 $8,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of First Command Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on First Command Financial Services, Inc. with notifications on news.